Talk to a clinician about evidence-based options
These clinical studies indicate that a topical product containing GHK-Cu may be administered for 4-12 weeks to improve the appearance, texture, and health of the skin
How can a laboratory select and use a pathway probe with enough confidence that observed biology is not simply an artifact of concentration drift, stability behavior, solvent mismatch, or assay interference
From 2004 to 2009, an analysis of the database revealed a six-fold increase in pancreatitis incidents linked to the DPP-4 inhibitor sitagliptin and the GLP-1 mimetic exenatide, the first two GLP-1-based medications marketed in the US [51]
How GHK Cu Works in the Body GHK Cu works at a cellular level by signaling the body to activate repair and regeneration processes
Retatrutide is currently in Phase 2 clinical trials